US Patent Issued to THE SCRIPPS RESEARCH INSTITUTE on June 17 for "Long-acting dual GIP/GLP-1 peptide conjugates and methods of use" (Chinese, American Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,823, issued on June 17, was assigned to THE SCRIPPS RESEARCH INSTITUTE (La Jolla, Calif.).

"Long-acting dual GIP/GLP-1 peptide conjugates and methods of use" was invented by Weijun Shen (Shenzhen, China), Zaid Amso (El Cajon, Calif.) and Peter G. Schultz (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are peptides and peptide conjugates comprising a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. The peptides may be used for blood glucose management and treating conditions such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH)...